The First Retinal Gene Therapy Trial

AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical TrialПодробнее

Atsena Doses First Patient in XLRS Gene Therapy Clinical TrialПодробнее

ViGeneron Launches Clinical Trial of Gene Therapy for RP Caused by CNGA1 MutationsПодробнее

Lecture: The Clinical & Surgical Considerations of Gene Therapy in Retina PatientsПодробнее

Learning about Gene Therapy with Dr. Paul YangПодробнее

IRD Patient and Family Day 2024 | Gene therapy: a Luxturna implementation exampleПодробнее

Lecture: Gene Therapy for AMD: Are We There Yet?Подробнее

VISIONS 2022 | Clinical & Research Updates: Retinitis Pigmentosa (RP)Подробнее

Eye on the Cure Podcast | Episode 59: Dr. Robert MacLarenПодробнее

Inherited Retinal Disease (IRDs): Approach to Patients andthe Top Genes (9 Apr 2024)Подробнее

Update on Gene Therapy Clinical TrialsПодробнее

Gene therapies and stem cell research: now and in the futureПодробнее

2022 GFPD Family & Scientific Conference: PEX1 Retinal Gene Therapy project updateПодробнее

Gene therapy – does it always have to be gene specific ？Подробнее

Recent Advances in Artificial Retina, Stem Cell & Gene Therapy: VR Conference at THONEH, MalaysiaПодробнее

Role of gene therapy for Retinal Dystrophies and Retinitis Pigmentosa#genetherapy#blindness#researchПодробнее

2022 GFPD Family & Scientific Conference: Retinal Gene Therapy SessionПодробнее

Lecture: Past, Present and Future: Treatment of Inherited Retinal Diseases (IRDs)Подробнее

Retina UK Annual Conference 2023: Practical example of gene therapyПодробнее

Emerging Therapies for Inherited Retinal DiseasesПодробнее